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Abstract
Older adults and special populations (living with disability and/or chronic illness that may limit mobility and/or
physical endurance) can benefit from practicing a more physically active lifestyle, typically by increasing ambulatory
activity. Step counting devices (accelerometers and pedometers) offer an opportunity to monitor daily ambulatory
activity; however, an appropriate translation of public health guidelines in terms of steps/day is unknown. Therefore
this review was conducted to translate public health recommendations in terms of steps/day. Normative data
indicates that 1) healthy older adults average 2,000-9,000 steps/day, and 2) special populations average 1,200-8,800
steps/day. Pedometer-based interventions in older adults and special populations elicit a weighted increase of
approximately 775 steps/day (or an effect size of 0.26) and 2,215 steps/day (or an effect size of 0.67), respectively.
There is no evidence to inform a moderate intensity cadence (i.e., steps/minute) in older adults at this time.
However, using the adult cadence of 100 steps/minute to demark the lower end of an absolutely-defined
moderate intensity (i.e., 3 METs), and multiplying this by 30 minutes produces a reasonable heuristic (i.e., guiding)
value of 3,000 steps. However, this cadence may be unattainable in some frail/diseased populations. Regardless, to
truly translate public health guidelines, these steps should be taken over and above activities performed in the
course of daily living, be of at least moderate intensity accumulated in minimally 10 minute bouts, and add up to
at least 150 minutes over the week. Considering a daily background of 5,000 steps/day (which may actually be too
high for some older adults and/or special populations), a computed translation approximates 8,000 steps on days
that include a target of achieving 30 minutes of moderate-to-vigorous physical activity (MVPA), and approximately
7,100 steps/day if averaged over a week. Measured directly and including these background activities, the evidence
suggests that 30 minutes of daily MVPA accumulated in addition to habitual daily activities in healthy older adults
is equivalent to taking approximately 7,000-10,000 steps/day. Those living with disability and/or chronic illness (that
limits mobility and or/physical endurance) display lower levels of background daily activity, and this will affect
whole-day estimates of recommended physical activity.
Introduction
The profound and multiple benefits of living a physically
active lifestyle extend to older adults and special popula-
tions (living with disability and/or chronic illness that
may limit mobility and/or physical endurance) [1]. In
reviewing their 2008 release of federal physical activity
guidelines, the U.S. Advisory Committee Report
concluded that, in addition to the well known cardiovas-
cular and metabolic health benefits, there was “strong
evidence” that physically active older adults have higher
levels of functional health, lower risks of falling, and
improved cognitive health [2]. A recent systematic
review further confirmed that greater aerobic physical
activity was associated with reduced risk of functional
limitations and disability with age [3]. A systematic
review of the benefits of physical activity for special
populations is lacking, but it is presumed that similar
returns are reasonable to expect.
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Evidence-based guidelines for older adults communi-
cate the benefits of a physically active lifestyle using
frequency-, duration-, and intensity-based parameters.
Similar to what is typically communicated to younger
adults, public health physical activity guidelines pro-
mote at least 150 minutes/week of moderate-to-vigor-
ous physical activity (MVPA) for older adults and
include “brisk walking” as a primary example of an
appropriate activity [3]. Variations on the message
exist: the World Health Organization promotes at least
30 minutes of moderate intensity physical activity 5
days per week for older adults [4]. All older adults
should avoid inactivity and some physical activity is
considered better than none [5]; however, public health
recommendations answer a pragmatic need to provide
generalized guidance. Regardless of the message speci-
fics, as framed, time- and intensity-based guidelines
imply that this dose of physical activity should be
taken over and above a baseline level which is yet to
be quantified. This is problematic, since it is likely that
this baseline level of non-exercise physical activity has
been most susceptible to secular transitions in occupa-
tion in favour of desk jobs and reductions in physical
demands of most other jobs, reliance on labour-saving
devices to supplement or replace domestic tasks and
other activities of daily living, dependence on motor-
ized transportation, and an insidious and pervasive
predilection for passive leisure time pursuits [6]. Since
self-reported leisure time physical activity (specifically
walking for exercise) increases in older adults with age
[7], yet objectively monitored physical activity
decreases [8], it is also likely that this baseline level of
non-exercise physical activity is vulnerable to advan-
cing age, disability, and chronic illness.
Step counting devices (i.e., pedometers and acceler-
ometers) provide a means of objectively quantifying
total daily activity, and their counting mechanisms are
particularly sensitive to detecting the recommended
intensities of walking believed to be associated with a
host of healthful outcomes for older adults. Acceler-
ometers can provide additional data with regards to
time spent in various intensities of physical activity and
inactivity in addition to providing step data. However,
due to their relative expense and associated intensive
data management requirements their use is typically
limited to research. In contrast, simple and inexpensive
pedometers, even if they are less sensitive to very slow
walking [9], are more likely to be adopted for clinical
and real world applications, including direct use by
members of the public. Regardless of instrumentation
choice, the utility of any step output is limited without
the ability to translate public health guidelines in terms
of steps/day.
Methods
The Public Health Agency of Canada (PHAC) commis-
sioned a literature review in February 2010 to inform an
evidence-based approach to converting step count data
into minutes of active time congruent with public health
guidelines. An English-language search strategy identi-
fied 1,594 articles published since 2000 using the key-
words (pedomet* or acceleromet*) and step* and
((physical activity) or walk*) within the following search
engines: CINAHL, ERIC, MEDLINE, PsycINFO, SocIN-
DEX, and SPORTDiscus. The list was subsequently
reduced to 837 articles after duplicates, remaining non-
English language articles, dissertations, non-peer
reviewed articles, and those obviously not dealing with
step-defined human physical activity were removed.
Abstracts were reviewed, identified articles were
assembled, and a report was written. Selected research-
ers from around the world with first-hand experience
collecting step data in the relevant population were
invited to critically review the report, identify any gaps
or offer additional literature, check and verify data
pulled from original sources, and intellectually contri-
bute to this consensus article.
For the purposes of this article, we defined older
adults as those older than 65 years of age, although
much of the identified literature represents even older
individuals. At times we considered studies that
included at least some participants under 65 years of
age, for example, as low as 50 years of age if the sample
mean age was over 65 years of age. The definition of
special populations was purposely quite broad and
included studies of individuals living with disability and/
or chronic illness that may limit mobility and/or physi-
cal endurance. Older adults with disabilities or chronic
health problems, and frail older adults would more
appropriately fit into the special populations category,
however, this category is not necessarily defined solely
by age. The final product herein is centred on the litera-
ture relevant to older adults and special populations
with regards to: 1) normative data (i.e., expected values);
2) changes expected from interventions; 3) controlled
studies that determine exact step-based conversions of
timed behaviour; 4) computing a step translation of
time- and intensity-based physical activity guidelines (e.
g., steps/day associated with time in moderate-to-vigor-
ous physical activity or MVPA); 5) directly measured
steps/day indicative of minimal time in MVPA taken
under free-living conditions; and, 6) steps/day associated
with various health outcomes. Each section represents a
‘mini-review.’ At times the search strategy was exhaus-
tive and the exact number of articles identified is pre-
sented under the appropriate heading below (e.g., direct
studies of step-equivalents of physical activity
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guidelines). Where current reviews were identified (e.g.,
normative data), the findings were simply summarized
herein and select original articles were referred to only
to make specific points. Where appropriate, details of
studies were tabulated. Any apparent inconsistencies in
reporting within tables (e.g., instrument brand, model,
manner in which participant age is reported, etc.) reflect
reporting inconsistencies extracted directly from original
articles. The child/adolescent [10] and adult populations
[11] literature is reviewed separately.
Results
Normative data (expected values)
An early review of normative data from studies pub-
lished between 1980 and 2000 [12] reported that we can
expect 1) healthy older adults to take 6,000-8,500 steps/
day (based on 10 studies identified that included adults
age 50+ years with no specifically reported disabilities or
chronic conditions); and 2) special populations to take
3,500- 5,500 steps/day (based on 8 studies identified
representing a broad range of disabilities and chronic ill-
nesses). The authors acknowledged that these expected
values were derived from an amalgamation of few and
disparate studies published at that time. Further, they
anticipated that these normative data would and should
be modified and refined as evidence and experience
using pedometers to assess physical activity would inevi-
tably continue to accumulate.
Since that time a number of studies focused on objec-
tively monitored data have been published and the
expected values for healthy older adults have been
updated [13]. Specifically, 28 studies published between
2001 and 2009 focusing on adults ≥50 years of age not
specifically recruited for illness or disability status were
identified and assembled in a review article [13]. Step-
defined physical activity ranged from 2,000- 9,000 steps/
day, was (generally) lower for women than men,
appeared to decrease over reported age groups, and was
lower for those defined as overweight/obese compared
to normal weight samples. A separate review article [14]
summarized expected values from 60 studies of special
populations including those living with heart and vascu-
lar diseases, chronic obstructive pulmonary disease or
COPD, diabetes and dialysis, breast cancer, neuromus-
cular diseases, arthritis, joint replacement, fibromyalgia,
and disability (impaired cognitive function/intellectual
difficulties). Older adults with disabilities took the low-
est number of steps/day (1,214 steps/day) followed by
individuals living with COPD (2,237 steps/day). The
highest number of steps/day (8,008 steps/day) were
taken by individuals with Type 1 diabetes, followed by
those living with mental retardation/intellectual disabil-
ity (7,787 steps/day) and HIV (7,545 steps/day). It is
apparent that special populations, broadly defined,
include those whose disability and/or chronic illness
may or may not limit their mobility and/or physical
endurance.
Tudor-Locke and Bassett [15] originally proposed a
graduated step index to describe pedometer-determined
habitual physical activity in adults: 1) < 5,000 steps/day
(sedentary); 2) 5,000-7,499 steps/day (low active); 3)
7,500-9,999 steps/day (somewhat active); 4) ≥ 10,000-
12,499 steps/day (active); and 5) ≥12,500 steps/day
(highly active). These incremental categories were rein-
forced in a second review in 2008 [16]. Recognizing a
considerable floor effect (i.e., insensitivity to the range
of activity levels below the lowest threshold) when
applied to low active populations, Tudor-Locke et al.
[17] suggested that the original sedentary level could be
further divided into two additional incremental levels: <
2,500 steps/day (basal activity) and 2,500- 4,999 steps/
day (limited activity). As it stands, this graduated step
index represents an absolute classification scheme. For
example, it does not take into consideration that advan-
cing age or the presence of chronic disease/disability
generally reduces levels of activity. As such older adults
and special populations will be always compared to
younger populations with less disability or illness.
Table 1 displays those studies of free-living behaviour
reporting the percent meeting select step-defined cut
points in older adults and special populations (specifi-
cally individuals living with HIV [18], as no other rele-
vant article was located on special populations). These
limited studies indicate that achieving > 10,000 steps/
day is likely to be challenging for some (e.g., those tak-
ing less than 2,500 steps/day), but not necessarily
impossible for all older adults (e.g., those taking more
than 9,000 steps/day).
In summary, the updated normative data indicate that
1) apparently healthy older adults average 2,000-9,000
steps/day, and 2) special populations average 1,200-
8,800 steps/day. The very broad ranges of habitual activ-
ity reflect the natural diversity of abilities common to
older adults and special populations, especially given
that not all chronic conditions are expected to signifi-
cantly impact physical mobility and/or endurance.
Further, individuals with a chronic illness are not neces-
sarily “older,” further exacerbating this wide variability.
Normative data continue to be published. These norma-
tive data provide an important set of reference values by
which individual or group data can be compared to
assumed peers. Use of a graduated step index permits
classification of older adults and special populations by
multiple step-defined physical activity categories. On-
going surveillance of step-defined physical activity is
required to track progress, identify areas of concern,
and evaluate the efficacy and effectiveness of public
health strategies. The next step will be to improve
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understanding about determinants of step-defined physi-
cal activity, including the impact of disability and
chronic illness on contexts (e.g., occupation, retirement,
transport, leisure, home, living arrangements, etc.)
where older adults and special populations accumulate
(or do not accumulate) steps, especially those of at least
moderate intensity (defined below).
Interventions
Although three previous reviews have documented the
effects of pedometer-based programming on physical
activity [19-21], weight loss [19,20], and blood pressure
[19] in samples that have included older adults and spe-
cial populations, no review has specifically examined
intervention effects in either of these groups at this
time. Yet these are the groups that may be most
attracted to pedometer-based programming. Participants
in pedometer-based community interventions delivered
in Ghent, Belgium [22] and Rockhampton, Australia
[23] were more likely to be older than younger.
Although no actual pedometer data were reported, a
library-based pedometer loan program delivered in
Ontario, Canada reported that older adults (55+ years of
age) were more likely to participate than other age
groups.
Table 2 presents details from 13 identified pedometer-
based physical activity intervention studies that have
focused on older adult samples ranging in age from 55
to 95 years. The majority of participants were commu-
nity-dwelling, however a few studies reported interven-
tions with older adults living in continuing care [24],
congregate housing [25], or assisted living situations
[26]. Interventions have lasted from 2 weeks [24] to 11
months [27] in duration. The mean baseline step-
defined physical activity was 4,196 steps/day (weighted
mean = 3,556 steps/day); a value that is considered
representative of sedentary populations [15]. The mean
delta (i.e., difference between pre- and post-intervention)
was 808 steps/day; adjusted for sample size the weighted
mean delta was 775 steps/day. In comparison, a change
of 2,000-2,500 steps/day is typical of pedometer-based
interventions in younger adults [19,21]. Study-specific
effect sizes (Cohen’s D) were computed where necessary
data were provided in the original article, and these also
appear in Table 2. Overall, the weighted effect size was
0.26 (generally considered a small effect). This effect
size is also smaller than what is expected in younger
adult populations (i.e., 0.68) [21].
Table 3 displays details from identified pedometer-
based physical activity intervention studies in special
populations that have reported any steps/day data. Spe-
cifically, we located 10 studies in cancer populations,
three in COPD populations, two in coronary heart dis-
ease and related disorders, 15 in diabetes populations,
and 3 in populations with joint or muscle disorders.
Across conditions, intervention durations have ranged
from 4 weeks [28,29] to 12 months [30,31]. Some
researchers have chosen to intervene using a ped-
ometer but to assess outcomes using an accelerometer
[31-36]. Delta values and effect sizes were computed
for each study where requisite data were reported.
Additionally, we have presented unweighted and
weighted (taking into consideration sample size) deltas
and effect sizes by condition. Mean weighted deltas
ranged from 562 steps/day for COPD to 2,840 steps/
day for coronary heart disease and related disorders.
Weighted effect sizes ranged from 0.06 (small) for
COPD to 1.21 (large) for coronary heart disease and
related disorders. Across conditions, unweighted mean
delta and effect size were 2,072 steps/day and 0.64,
respectively. Weighted values were 2,215 and 0.67
(medium), respectively.
Table 1 Studies of free-living behaviour reporting percent meeting select step-defined cut points in older adults
First
Author
Sample Characteristics Instrument Monitoring
Frame
Cut points
used
% Meeting
Specified Cut Point
Tudor-
Locke
[37]
2002
Canada
6 men, 12 women;
Community dwelling
older exercisers;
59-80 years
Yamax Digiwalker SW-200, Yamax
Corporation, Tokyo, Japan
9 days 10,000 50% never achieved 10,000 steps on any
day of the monitoring frame
Newton
[58]
2006
UK
54 women;
primary biliary cirrhosis
patients
63.0 ± 9.4 years
Actigraph MTI Health Services, USA 6 days Adult Graded
Step Index
24% > 10,000
Rowe [55]
2007
UK
29 men, 60 women
community dwelling
60+ years
Yamax
Actigraph
7 days 10,000 9.6% of days > 10,000
Ewald
[88]
2009
Australia
322 men, 362 women;
community-dwelling,
urban;
55 to 85 years
Yamax Digwalker SW-200 7 days 8,000 [84] Overall: 42% > 8,000
55-59 year olds: 62%
80+ year olds: 12%
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Controlled studies
Controlled studies conducted on treadmills or desig-
nated walking courses can provide direct information
about the number of steps in continuous timed walks.
The only study identified that focused on older adults
was conducted by Tudor-Locke et al. [37] who reported
that community-dwelling older adults (mean age 69
years) who were regular exercisers (confirmed by regular
attendance at exercise classes that they were recruited
from) took approximately 3,400 steps in a 30-minute
timed group exercise walk (translating to a cadence or
stepping rate of approximately 113 steps/minute)
Table 2 Pedometer -based physical activity intervention studies with older adults
Reference Sample Intervention
duration; study
duration and design
Instrument Intervention
Group
Baseline
Steps/day
Intervention
Group
Immediately
Post-
Intervention
Steps/day
Delta
Steps/
day
Cohen’s
D
Conn [89]
2003
USA
65-96 years; community-
dwelling;
190 participants
3-month intervention;
3-month randomized
controlled trial
Yamax Digi-Walker 2,773 ± 1,780 2,253 ± 1,394 -520 -0.33
Croteau [26]
2004
USA
68-95 years; living in assisted
living; 15 participants
4-week intervention; 4-
week quasi-
experimental
Yamax Digi-Walker SW-
200
3,031 ± 2,754 2,419 ± 2,296 -612 -0.24
Jensen [90]
2004
USA
60-75 years; community
-dwelling; 18 participants
3-month intervention;
3-month quasi-
experimental
Accusplit, San Jose, CA 4,027 ± 2,515 5,883 ± 3,214 1,856 0.65
Croteau [25]
2005
USA
60-90 year olds;
living in congregate housing
or community-dwelling; 76
participants
4- month intervention;
4-month quasi-
experimental
Accusplit AX120, San
Jose, California
4,041 ± 2,824 5,559 ± 3,866 1,518 0.45
Croteau [91]
2007
USA
55-94 years; community-
dwelling; 147 participants
12-week intervention;
12-week quasi-
experimental
Yamax Digi-Walker SW-
200 (Yamax Corporation,
Tokyo, Japan)
4,963 ≅ 6,200 ≅
1,237
N/A
Sarkisian
[92]
2007
USA
≥ 65 years; community-
dwelling; 46 participants
7-week intervention; 7-
week quasi-
experimental
Digiwalker (Yamax DW-
500, New Lifestyles, Inc.,
Kansas City, MO)
3,536 ± 2,280* 4,387 ± 2,770* 851 0.34
Wellman
[93]
2007
USA
Mean 74.6 years;
community-dwelling; 320
participants
12-week intervention;
12-week quasi-
experimental
NR 3,110 ± 2,448 4,183 ± 3,257 1,073 0.38
Rosenberg
[24]
2008
USA
74-92 years; living in
continuing care retirement
community; 12 participants
2 week intervention; 3-
week quasi-
experimental
Accusplit AH120M9,
Pleasanton, CA
3,020 ± 1,858 4,246 ± 2,331 1,226 0.59
Culos-Reed
[94]
2008
Canada
46-83 years; community-
dwelling; 39 participants
8-week intervention; 8-
week quasi-
experimental
NR 5,055 ± 1,374 5,969 ± 1,543 914 0.63
Fitzpatrick
[95]
2008
USA
Mean 75 years;
attending senior centers;
418 participants
4-month intervention;
4-month quasi-
experimental
Accusplit, San Jose, CA 2,895 ± 2,170 3,743 ± 2,311 848 0.38
Opdenacker
[27]
2008
Belgium
≥ 60 years; community-
dwelling; 46 intervention
participants
11-month intervention;
23-month randomized
controlled trial
Yamax Digiwalker SW-
200, Yamax Corporation,
Tokyo, Japan
7,390 ±
2,693**
7,465 ± 3,344** 75 0.02
Sugden [96]
2008
U.K.
70-86 years; community-
dwelling;
54 participants
12-week intervention;
12-week randomized
controlled trial
Omron HJ-005 2,895 NR N/A N/A
Koizumi [97]
2009
Japan
60-78 years; community-
dwelling; 34 intervention
participants
12-week intervention;
12-week randomized
controlled trial
Kenz Lifecorder,
Suzuken Company,
Nagoya, Japan
7,811 ± 3,268 9,046 ± 2,620 1,235 0.42
Steps/day presented as mean ± SD unless otherwise noted; *reported as steps/week in original article; divided by 7 days here; **SD calculated from reported SE
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Table 3 Pedometer - based physical activity intervention studies with special populations
Reference Sample Intervention duration;
study duration and
design
Instrument Intervention
Group
Baseline Steps/
day
Intervention
Group
Immediately
Post-
Intervention
Steps/day
Delta
Steps/day
Cohen’s D
Cancer
Wilson [98]
2005
USA
Adult breast cancer
survivors; 22 intervention
participants
8-week intervention;
8-week quasi-
experimental
NR 4,791 8,297 3,506 N/A
Pinto [32,33]
2005, 2009
USA
Adult breast cancer
survivors; 43 intervention
participants
12-week intervention; 9-
month randomized
controlled trial
Intervention:
pedometer
(Yamax
Digiwalker)
Assessment:
accelerometer
(Caltrac, Muscle
Dynamics,
Torrance, CA)
4,471.7 ± 5,196.1 14,571.5 ±
9,489.5
10,100 1.38
Vallance [99]
2007
Canada
Adult breast cancer
survivors; 94 print
materials, 94 pedometer
only, 93 pedometer with
print materials, 96
standard
recommendation
3-month intervention; 6-
month randomized
controlled trial
Digi-Walker SW-
200 PED (New
Lifestyles Inc.,
Lee’s Summit,
MO)
8,476 ± 3,248
(Pedometer
only)
7,993 ± 3,559
(Pedometer with
print materials)
8,420 ± 5,226
(Pedometer
only)
7,783 ± 3,048
(Pedometer
with print
materials)
-210 -0.06
Irwin [100]
2008
USA
Adults with early stage
breast cancer; 37
intervention participants
6-month intervention; 6-
month randomized
controlled trial
NR 5,083 ± 2,313
(based on n =
37)
6,738 ± 2,958
(based on n
= 34)
1,655 0.63
Pinto [34]
2008
USA
Breast cancer survivors;
25 intervention
participants
12-week intervention; 24-
week quasi-experimental
Intervention:
pedometer
(Yamax
Digiwalker)
Assessment:
accelerometer
(Biotrainer-Pro,
Individual
Monitoring
Systems,
Baltimore, MD)
No pre-
intervention
steps data
reported but
week one mean
steps/day =
515.8 ± 470.8
1,695.4 ±
1,221.3
1,180 1.39
Matthews
[35]
2007
USA
Breast cancer survivors;
13 intervention
participants
12-week intervention; 12-
week randomized
comparative trial
Intervention:
pedometer
(Brand NR)
Assessment:
Manufacturing
Technology
Actigraph (MTI,
Fort Walton
Beach, FL, USA)
7,409.4 ± 2,791.1 8,561.8 ±
2887.3
1,152 0.41
Blaauwbroek
[101]
2009
The
Netherlands
Adult survivors of
childhood cancer; 38
intervention participants
10-week intervention; 36-
week quasi-experimental
Yamax digiwalker
SW-200
7,653 ± 3,272 11,803 ±
3,483
4,150 1.23
Mustian [28]
2009
USA
Mixed cancer type
patients receiving
radiation; 19 intervention
participants
4-week intervention; 3-
month randomized
controlled trial
NR 7,222 ± 2,691 11,200 ±
5,851
3,978 0.93
Swenson [30]
2010
USA
Breast cancer patients
receiving chemotherapy;
36 intervention
participants (subsample
of larger randomized
trial)
12- month intervention;
12-month quasi-
experimental study
conducted within a larger
randomized trial
Walk 4 Life
LS2500 (Walk 4
Life, Inc.)
No pre-
intervention
steps data
reported but
week one mean
steps/day =
7,453 ± 2,519
9,429 ± 3,488 1,976 0.66
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Table 3 Pedometer - based physical activity intervention studies with special populations (Continued)
Unweighted
mean
2,743 0.73
Weighted
mean
2,139 0.51
Chronic obstructive pulmonary disease (COPD)
De Blok [102]
2006
The
Netherlands
Adults with COPD; 8
intervention participants
9-week intervention; 9
week randomized
controlled trial
Yamax Digi-
Walker SW-200
(Tokyo, Japan)
2,140 3,927 1,787 N/A
Hopses [103]
2009
The
Netherlands
Adults with COPD; 18
intervention participants
12-week intervention; 12-
week randomized
controlled trial
Digiwalker SW-
2000 (Yamax,
Tokyo, Japan)
7,087 ± 4,058 7,872 ± 3,962 785 0.20
Nguyen [36]
2009
USA
Adults with COPD; 8 self-
monitored (SM), 9
coached (C)
6-month intervention; 6-
month randomized
comparative trial of cell-
phone supported
pedometer programs
Intervention:
Omron HJ-112
(Omron
Healthcare,
Bannockburn, IL,
USA)
Assessment:
Stepwatch 3
Activity Monitor
(SAM; OrthoCare
Innovations,
Washington, DC,
USA)
SM:
5,229 ± 3,021*
C:
6,692 ± 3,021*
SM:
5,838 ±
3,100*
C:
5,675 ±
3,021*
SM:
609
C:
-1,017
SM: 0.02
C:
-0.34
Unweighted
mean
541 0.02
Weighted
mean
562 0.06
Coronary heart disease and related disorders
VanWormer
[104]
2004
USA
Adults with coronary
artery disease; 22
intervention participants
17-week intervention; 17-
week quasi-experimental
NR 6,520.10 ±
2,926.99
8,210.24 ±
2,534.91
1,690 0.62
Izawa
[105] 2005
Japan
Adult myocardial
infarction patients
completing 6 months of
cardiac rehabilitation;
24 intervention
participants
6-month intervention; 12-
month randomized
controlled trial
Kenz Lifecorder,
(Suzuken, Nagoya,
Japan)
6,564.9 ± 1,114.6 10,458.7 ±
3,310.1
3,894 1.76
Unweighted
mean
2,792 1.29
Weighted
mean
2,840 1.21
Diabetes and related disorders
Tudor-Locke
[29]
2001
Canada
Adults with type 2
diabetes; 9 intervention
participants
4-week intervention; 4-
week quasi-experimental
Yamax Digiwalker
SW-200
6,342 ± 2,244 10,115 ±
3,407
3,773 1.34
Tudor-Locke
[106]
2004
Canada
Adults with type 2
diabetes; 24 intervention
participants
16-week intervention; 24-
week randomized
controlled trial
Yamax SW-200,
(Yamax
Corporation,
Tokyo, Japan)
5,754 ± 2,457 9,123 ± 4,539 3,369 0.96
Araiza [107]
2006
USA
Adults with type 2
diabetes; 15 intervention
participants
6-week intervention; 6-
week; randomized
controlled trial
Yamax Digiwalker
SW-701 (New
Lifestyles, Kansas
City, MI)
7,220 ± 2792 10,410 ±
4,162
3,190 0.92
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Table 3 Pedometer - based physical activity intervention studies with special populations (Continued)
Engel [108]
2006
Australia
Adults with type 2
diabetes; 30 coaching
intervention, 24
pedometer intervention
6-month intervention; 6-
month randomized
comparative trial
Yamax Digi-
Walker-700
NR averaged
7,296 ± 2,066
during
intervention
N/A N/A
Richardson
[109]
2007
USA
Adults with type 2
diabetes; 17 lifestyle
goals, 13 structured goals
6-week intervention;
6-week comparative trial
of two types of
pedometer goal-setting
strategies
Omron HJ-720IT
(beta test version)
Lifestyles goals:
4,157 ± 1,737
Structured goals:
6,279 ± 3,306
Lifestyles
goals:
5,171 ± 1,769
Structured
goals:
6,868 ± 3,751
Lifestyles
goals:
1,014
Structured
goals:
589
Lifestyles
goals:
0.58
Structured
goals:
0.17
Bjorgaas
[110]
2008
Norway
Adults with type 2
diabetes; 19 intervention
participants
6-month intervention;
6-month randomized
controlled trial
Yamax Dig-Walker
ML AW-320,
Yamax Corp,
Tokyo, Japan
7,628 ± 3,715 8,022 ± 3,368 394 0.11
LeMaster [31]
2008
USA
Adults with diabetic
peripheral neuropathy;
41 intervention
participants
12-month intervention;
12-month randomized
controlled trial
Intervention:
Accusplit Eagle
170 (Pleasanton,
CA)
Assessment:
Stepwatch 3
(Orthocare
Innovations,
Washington, DC)
3,335 ± 1,575* 3,183 ±
1,537*
-152 -0.10
Cheong
[111]
2009
Canada
Adults with type 2
diabetes; 19 pedometer-
only intervention (P); 19
pedometer and low
glycemic index food
intake intervention (PGI)
16-week intervention; 16-
week randomized
comparative trial
NR P:
5,721 ± 2,232*
PGI:
5,251 ± 1,944*
P:
8,527 ±
3,374*
PGI:
9,381 ±
5,187*
P:
2,806
PGI:
4,130
P:
1.00
PGI:
1.16
Johnson
[112]
2009
Canada
Adults with type 2
diabetes; 21 Enhanced
program, 17 Basic
program
12-week randomized
comparative evaluation of
two types of pedometer
programs
Digi-Walker SW-
200, (Yamax,
Kyoto, Japan)
All participants:
8,948 ± 3,288
All
participants:
10,485 ±
4,264**
1,685 0.44
Kirk [113]
2009
U.K.
Adults with type 2
diabetes; 42 in-person
intervention (IP),
40 written form
intervention (WF)
6-month intervention; 12-
month randomized
controlled trial
ActiGraph GT1M
(ActiGraph LLC,
Pensacola, FL,
USA)
IP:
6,600 ± 2,700
WF:
5,500 ± 2,300
IP:
6,500 ± 2,300
WF:
5,300 ± 2,300
IP:
-100
WF:
-200
IP:
-0.04
WF:
-0.09
Newton
[114]
2009
New Zealand
Adolescents with type 1
diabetes; 34 intervention
participants
12-week intervention; 12-
week randomized
controlled trial
NR Median 11,242 Median
10,159
N/A N/A
Tudor-Locke
[115]
2009
Canada
Adults with type 2
diabetes; 157
professional-led (PRO), 63
peer-led (PEER)
participants
16-week intervention; 16-
week quasi-experimental
comparison of program
delivery
Yamax SW-200,
(Yamax
Corporation,
Tokyo, Japan)
PRO: 3,980 ±
2,189
PEER:
4,396 ± 2,045
PRO:
7,976 ± 4,118
PEER:
8,612 ± 3,202
PRO:
3,996
PEER:
4,216
PRO:
1.27
PEER:
1.61
Vincent [116]
2009
USA
Adults with type 2
diabetes; 9 intervention
participants
8-week intervention; 8-
week randomized
controlled trial
NR 4,175 7,238 3,063 N/A
De Greef [72]
2010
Belgium
Adults with type 2
diabetes; 20 intervention
participants
12-week intervention, 12-
week randomized
controlled trial
Yamax DigiWalker
SW200
7,099 ± 4,208 8,024 ± 5,331 925 0.19
Diedrich
[117]
2010
USA
Adults with type 2
diabetes; 11 intervention
participants
3-month intervention; 3-
month quasi-experiment
Yamax Digiwalker
SW-200
4,145 ± 2,929*** 6,486 ±
2,766***
2,341 0.82
Unweighted
mean
2,061 0.65
Weighted
mean
2,405 0.78
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around a gymnasium. Intensity was not directly mea-
sured and it is plausible that the group nature of the
walk influenced individual paces. However, the finding
does fit within estimates for the number of steps taken
in 30 minutes of moderate intensity walking in adults
[38,39] and within published normal cadence ranges
representing “free-speed walking” for men (81-125
steps/minute) and women (96-136 steps/minute) aged
65-80 years [40]. Studies conducted with younger adult
samples [41-45] that have directly measured the number
of steps and verified activity intensity in absolute terms
of metabolic equivalents or METs (1 MET = 3.5 ml O2/
kg/min or 1 kcal/kg/hour) have concluded that, despite
individual variation, a cadence of 100 steps/minute
represents a reasonable heuristic value for moderate
intensity walking. This suggests that 1,000 steps taken in
10 minutes of walking, or 3,000 steps taken in 30 min-
utes, could be used to indicate a floor value for abso-
lutely-defined moderate intensity walking. However, it is
important to note that this cadence may be unattainable
for some individuals living with disability or chronic dis-
ease (including frail older adults), reflecting known dif-
ferences between absolute and relative intensity with age
and illness [46]. Unfortunately, there are no data to spe-
cifically inform absolute or relative intensity of different
cadences in healthy older adults. With that being said, it
is possible that any increase in daily step count relative
to individualized baseline values could confer health
benefits. This is congruent with the now accepted con-
cept that some activity is better than none, and that
some relatively important health benefits may be rea-
lized even with improvements over the lowest levels [5].
In a clinically-based study, 64 older subjects with per-
ipheral artery disease (PAD) and claudication took 575
± 105 steps to ambulate 355 ± 74 meters during a 6-
minute walk test, equating to an average speed of 2.2
mph and an average cadence of 96 steps/min [47].
Given that these research participants were instructed to
cover as much distance as possible, this average cadence
represents a relatively high exercise intensity (i.e., possi-
bly exceeding moderate intensity, at least in terms of
relative intensity) in this population. This is confirmed
by the results of a separate study that demonstrated that
for these patients, walking at a slightly slower speed of
2.0 mph equates to an energy expenditure of approxi-
mately 70% of their peak oxygen uptake [48].
Walking at a cadence of 96 steps/min during a clinical
test represents a much higher ambulatory challenge
than that measured during free-living daily activities of
PAD patients monitored for one week with a step activ-
ity monitor [49]. The maximum cadence for one minute
of free-living ambulation (i.e., the minute with the single
highest cadence value each day) averaged 90.8 steps/
min, which was significantly lower than the average
value of 99 steps/min in age-matched control subjects
from the same study. The maximum cadence for 30
continuous minutes of ambulation each day was only 28
steps/min in PAD patients versus 35.4 steps/min in the
age-matched control subjects. Thus, the cadence
observed under testing conditions may not be represen-
tative of that performed during everyday life.
No other controlled study of cadence or steps taken in
timed walks related to intensity was identified for any
other special population group. However, the data in
Table 3 Pedometer - based physical activity intervention studies with special populations (Continued)
Joint or muscle disorders
Talbot [118]
2003
USA
Adults with knee
osteoarthritis; 17 walking
plus education program
12-week intervention; 12-
week randomized
comparative trial of a self-
management education
program with and
without walking program
New Lifestyles
Digi-walker SW-
200 (Yamax,
Tokyo, Japan)
3,519 ± 2,603 4,337 ± 2,903 818 0.30
Kilmer [119]
2005
USA
Adults with
neuromuscular disease;
20 intervention
participants
6-month intervention; 6-
month quasi-experimental
home-based activity and
dietary intervention
NR ≅ 4,600 (from
figure)
≅ 5,900 (from
figure)
N/A N/A
Fontaine
[120]
2007
USA
Adults with fibromyalgia
syndrome; 14
intervention particpants
12-week intervention; 12-
week randomized
comparative trial
Accusplit Eagle
Activity
Pedometer (San
Jose, CA)
2,337 ± 1,598* 3,970 ±
2,238*
1,633 0.85
Unweighted
mean
1,226 0.57
Weighted
mean
1,186 0.55
Note: Values are means ± SD unless otherwise stated, personal communication with Fontaine [120] clarified that what was reported in the published manuscript
was actually SE; COPD = Chronic obstructive pulmonary disease; *SD calculated from reported SE; * post-test data obtained directly from corresponding author;
***reported as steps/week in original article, divided by 7 days here.
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older adults with PAD indicate that the relative intensity
of walking speeds (captured as cadence) is higher for
some groups of older adults, particularly special popula-
tions living with disability or chronic illness, than for
younger and healthy adults [50,51]. Therefore, future
research is needed to extend values for measured
cadences, associated walking speeds, absolute intensity
(MET values), and ratings of perceived exertion and/or
heart rate (to assess relative intensity) in healthy older
adults across a range of abilities, as well as in disease-
specific populations. Although there appears to be gen-
eral agreement with regards to the cadence (i.e., 100
steps/min) associated with an absolute measure of mod-
erate intensity in younger adult samples [41-45], it is
likely that cadence associated with relative intensity will
differ between individuals in much the same manner as
heart rate.
Computed step count translations for physical activity
guidelines
Physical activity guidelines from around the world do
not generally recommend that older adults do less aero-
bic activity than younger adults [5,52]. If anything, there
seems to be even more emphasis on the importance of
obtaining adequate amounts of MVPA over and above
activities of daily living [3]. It therefore makes sense to
recommend a similar step-based translation of physical
activity guidelines for healthy older adults as for their
younger counterparts. However, in special populations,
specifically individuals (young or old) living with disabil-
ity and chronic illness, it is important to promote a phy-
sically active lifestyle to the fullest extent that it is
possible, even if this may fall short of general public
health recommendations. For these groups where an
absolute intensity or cadence interpretation may not be
realistic, a shift to promoting relative intensity (and
therefore relative cadence) may become increasingly
important to maintain physical function and indepen-
dence. In essence, for those living at the lowest levels of
habitual physical activity, the clinical perspective
becomes paramount and overtakes the need for more
generic public health messaging.
As noted above, there is no evidence to inform a mod-
erate intensity cadence specific to older adults at this
time. However, using the adult cadence of 100 steps/
minute to denote the floor of absolutely-defined moder-
ate intensity walking, and multiplying this by 30 min-
utes, produces an estimate of 3,000 steps. To be a true
translation of public health guidelines these steps should
be taken over and above activities of daily living, be of
at least moderate intensity accumulated in minimally 10
minute bouts, and add up to at least 150 minutes spread
out over the week [3,5,53]. Considering a background of
daily activity of 5,000 steps/day [15,16], a computed
translation of this recommendation produces an esti-
mate of approximately 8,000 on days that include a tar-
get of achieving 30 minutes of MVPA, but
approximately 7,100 steps/day if averaged over a week
(i.e., 7 days at 5,000 plus 15,000 steps of at least moder-
ate intensity). In reality, this background level of daily
activity is likely to vary, and it is possible that steps/day
values indicative of functional activities of daily living in
some older adults (especially special populations living
with disability or chronic illness) are much lower than
5,000 steps/day. Recognizing this potential, and as
described above, the adult graduated step index has
been extended to include ‘basal activity’ (< 2,500 steps/
day) and ‘limited activity’ (2,500-4,999 steps/day) [17].
Therefore, if we consider 2,500 steps/day as a general
indicator of basal activity in older adults and/or indivi-
duals living with disability or chronic illness, the mini-
mal estimate is 5,500 daily steps or 4,600 steps/day if
averaged over a week of free-living behaviour. Admit-
tedly, these estimates are based on assumed baseline
levels, but also an increment that is tied to a cadence
that has only been established as an indicator of abso-
lutely-defined moderate-intensity walking in younger
adults.
The results of the first computational strategy produce
a range of 7,100- 8,000 steps/day that should be compa-
tible with all but the most sedentary older adults (nor-
mative data indicate 2,000- 9,000 steps/day) [13,14] and
includes criterion referenced values for healthy body
mass index (BMI) status related to older women
(reviewed below; 8,000 steps/day for 60-94 year old
women [54]). However, the limited interventions to date
assembled in Table 2 suggest that it may be precisely
these most sedentary older adults who are recruited for
such pedometer-based interventions. The second strat-
egy produces a range of approximately 4,600- 5,500
steps/day, which seems reasonable for the most seden-
tary older adults (i.e., those taking < 2,500 steps/day),
typically characterized as living with disability and
chronic illness, but would under value the achievements
of more active older adults or those with chronic illness
that does not limit their physical mobility or endurance
capacity. Communication using a graduated step index
would span these two concerns by providing additional
“rungs on the ladder” that take into consideration indivi-
dual variability while still promoting healthful increases
in physical activity. Barring health issues that might
compromise abilities, there appears to be no need to
otherwise reduce physical activity guidelines for appar-
ently healthy older adults (compared to those for young
to middle-aged adults). Any lower accommodation is
only in recognition of anyone (including both younger
adults and older adults) living with disabilities or
chronic illness that challenge their physical abilities. It is
Tudor-Locke et al. International Journal of Behavioral Nutrition and Physical Activity 2011, 8:80
http://www.ijbnpa.org/content/8/1/80
Page 10 of 19
important to emphasize that both of the computational
strategies outlined above produce minimal (or thresh-
old) estimates and it is expected that even more physical
activity will be beneficial.
Direct studies of step equivalents of physical activity
guidelines
Rowe et al. [55] studied older adults’ (60+ years of age)
pedometer-determined steps/day and used a Receiver
Operating Curve (ROC) analysis to inform maximal
classification accuracy related to 30+ minutes of acceler-
ometer-determined MVPA. They reported that 6,200-
6,800 steps/day taken in the course of everyday life was
congruent with the time-and intensity-based guidelines
if discontinuous (i.e., interrupted) minutes of MVPA
were accepted and 7,000-8,000 steps/day if 30 minutes
of continuous (bouts ≥ 10 minutes) MVPA was
required.
Aoyagi and Shephard [56] reviewed results of a num-
ber of studies based on the Nakanajo Study of Older
Adults and shared data related to patterns of physical
activity collected using an accelerometer (modified Kenz
Lifecorder, Suzuken Co., Ltd., Nagoya, Aichi, Japan) that
detected both steps and time in MVPA defined as > 3
METs. They reported a strong (r2 = .93) correlation
between the two outputs such that those who took <
2,000 steps/day spent almost no time in MVPA. From
that point, each 1,000 step increment in daily free-living
activity up to 6,000 steps/day was associated with an
additional 2.5 minutes of MVPA. From 6,000- 12,000
steps/day each 1,000 step increment added another 5
minutes of MVPA. Corresponding increases in MVPA
associated with an additional 1,000 steps from 12,000-
18,000 steps/day and above 18,000 steps/day were 7.5
minutes and 10 minutes, respectively. These findings
indicate that 30 minutes of MVPA is associated with
10,000 steps/day in older adults (computing a running
total from the details reported above). To be clear,
although continuous walking performed under labora-
tory conditions consistently demonstrates that 1,000
steps taken continuously over 10 minutes meets the cri-
terion for absolutely-defined moderate intensity [41-45],
step accumulation patterns under free-living conditions
include lighter intensity activities and ultimately suggest
that substantially more total steps must be accrued in
order to achieve recommended amounts of MVPA per-
formed in the course of daily living.
Ayabe et al. [57] also used a Suzuken Lifecorder accel-
erometer to record both step and physical activity
energy expenditure (PAEE) among cardiac rehabilitation
patients. Steps/day correlated strongly with PAEE (r =
.92) and with time spent in MVPA (r = .85). Achieve-
ment of minimal amounts of recommended PAEE (i.e.,
1,500 kcal/week) corresponded with a daily total of
6,470 steps/day and optimal amounts (i.e., 2,200 kcal/
week) corresponded with 8,496 steps/day.
In summary, the evidence suggests that, in apparently
healthy older adults, taking approximately 7,000-10,000
steps/day under free-living conditions is equivalent to
accumulating 30 minutes/day of MVPA (as detected by
accelerometer). The only direct evidence of a steps/day
equivalent of recommended amounts of MVPA that is
specific to any special population (in this case, cardiac
rehabilitation patients) indicates that minimal and opti-
mal amounts of PAEE are accumulated with approxi-
mately 6,500-8,500 steps/day, respectively. The evidence
to support a more specific translation of public health
guidelines into steps/day for special populations is lack-
ing. In addition, as presented above, the wide variety
and types of disabilities observed in special populations
may limit individual ability to perform exercise at any
rigidly defined absolute moderate intensity, thus requir-
ing a shift toward clinical strategies focused on relative
goal attainment and related improvements.
Steps/day associated with various health outcomes
Eight cross-sectional studies have focused on older
adults. Newton et al. [58] found that accumulating over
7,500 steps/day was related to reduced perceptions of
fatigue in older women (mean age 63 years) with a diag-
nosis of primary biliary cirrhosis. This was the only
study of steps/day associated with any health outcome
identified in any special population.
Yasunaga et al. [59] split total values of steps/day into
quartiles and reported concurrently accumulated time in
MVPA (from the same instrument; Suzuken Lifecorder)
and health-related quality of life (HRQoL) in older
adults. They reported that HRQoL was better in the sec-
ond quartile of steps/day (men: 5,500 steps/day and 13
minutes detected in moderate intensity; women: 4,500
steps/day and 14 minutes moderate intensity) compared
to the first quartile but that no additional benefit (smal-
ler and clinically insignificant improvements) was
observed with higher quartiles. Although these were
cross-sectional data, the authors suggested that an
increase of 2,000 steps over baseline might be recom-
mended for enhanced HRQoL in older adults. Park et
al. [60] conducted a similar analysis, this time focused
on presence vs. absence of metabolic syndrome in older
adults. They reported age-range specific results. They
observed a lower likelihood of metabolic syndrome in
65 to 74 year olds who took 10,000 steps/day and/or 30
minutes at > 3 METs (also from the same instrument;
Suzuken Lifecorder) and in those > 75 years of age who
took 8,000 steps/day and/or 20 minutes at > 3 METs.
Shimuzu et al. [61] studied the effects of habitual phy-
sical activity determined using a pedometer on an indi-
cator of immune functioning (salivary secretory
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immunoglobulin A or sIgA) in older Japanese adults
(aged 65-86 years). The steps/day data were split into
quartiles and the results showed that older adults who
took more than approximately 7,000 steps/day also had
the highest level of sIgA and this was significantly
higher compared to older adults who took < 4,600
steps/day. Mitsui et al. [62] also studied older (mean age
62.8 years) Japanese adults and reported that women
taking 7,500-9,999 steps/day had significantly lower BMI
and percent body fat than women taking < 5,000 steps/
day. Although this study failed to observe any significant
difference between those taking > 10,000 steps/day and
those taking < 5,000 steps/day, there were only 14/117
women who took > 10,000 steps/day. Thus, this study
was likely underpowered to identify small to modest dif-
ferences in BMI that might exist. In addition, obesity in
these older Japanese women was low (the mean BMI for
the sample was 22.2 kg/m2). The only significant differ-
ence in health parameters observed in men in this study
across step-defined physical activity was in triglycerol
levels; only men who took > 10,000 steps/day showed
significantly lower values.
Foley et al. [63] examined the relationship between
pedometer-determined steps/day and bone density at
the spine and hip in older adults between 50 and 80
years of age. In men and women over age 65, the
increasing difference in hip bone density ranged from
3.1% to 9.4% across the increasing steps/day quartiles.
The effect on the spine was only observed in women.
There was no threshold effect, that is, bone density con-
tinued to be higher with higher steps/day. In a second
study of older Japanese women (age 61 to 87 years of
age), Kitigawa et al. [64] observed a positive association
(adjusted for age and weight) between ultrasound-mea-
sured calcaneus bone density and steps/day up to a
maximum of 12,000 steps/day; thereafter additional
steps/day were not associated with any further increase
in bone density.
Tudor-Locke et al. [54] reported an age-specific analy-
sis of BMI-criterion referenced and amalgamated data
collected from around the world. For women aged 60-
94 years of age the best cut point was 8,000 steps/day in
terms of discriminating between BMI-defined normal
weight and overweight/obesity. In men aged 51-88 years
the value was 11,000 steps/day. The authors acknowl-
edged that they had better confidence in the women’s
data since the men’s value was based on a sparse sample
size collected over a relatively wider age range. It is
important to note that spring-levered pedometers are
known to undercount steps related to obesity [65], so
these BMI-referenced values can be questioned. How-
ever, even accelerometer-determined steps/day differ in
a similar pattern across BMI-defined obesity categories
[66]. Since pedometers are more likely to be used in
clinical and public health applications, it remains impor-
tant to present these pedometer-determined data as
indicators of expected values in these free-living popula-
tions (that include obese individuals).
Swartz et al. [67] conducted a simple analysis, report-
ing blood pressure and fasting glucose results in older
adults split by median pedometer-determined steps/day.
They reported that active older adults, defined by having
steps/day above the median value of 4,227 steps/day,
had lower blood pressure and fasting glucose. Since a
simple median split suggests only that “more is better,”
this study cannot be used to inform the dose response
relationship, nor can it be used to identify threshold
values of steps/day relative to lower blood pressure or
fasting glucose in older adults. Schmidt et al. [68] exam-
ined cardiometabolic risk, including measures of waist
circumference, systolic blood pressure, fasting glucose,
triglyceride, and HDL cholesterol, across the graduated
step index in a sample that included older adults. They
reported that individuals achieving ≥ 5,000 steps/day
had a substantially lower prevalence of adverse cardio-
metabolic health indicators.
In summary, based on these cross-sectional studies, it
appears that 4,500-5,500 steps/day is associated with
higher HRQoL scores [59] compared to that associated
with better measures of immunity (> 7,000 steps/day
[61]), metabolic syndrome (8,000-10,000 steps/day [60]),
or BMI-defined weight status (8,000-11,000 steps/day
[54,62]). Dose-response relationships may also be modi-
fied by sex [62,63]. The dose-response relationship with
bone density of the hip and, at least in women, spine,
appears to be linear and without threshold values [63].
The evidence indicating distinctly different dose-
response curves related to step-defined physical activity
is consistent with what was presented at a dose-response
symposium [69] and may not be limited to older adults
[70]. Of course, prospective and intervention studies are
needed to confirm any relationship between steps/day
and health outcomes. There is a general lack of any evi-
dence relative to special populations at this time.
Discussion
Monitoring steps taken is only one of many ways to
track physical activity and individuals may prefer to
count minutes in activity rather than wear any type of
step counting device. Step counting by definition is
most relevant to ambulatory activity; however, this is
not the only activity that can be performed at health-
related intensities. Other examples include cycling and
swimming. In addition, public health guidelines categori-
cally recognize the importance of other types of non-
ambulatory activity, including resistance training [3,5].
Therefore, the estimates contained herein are limited to
translations of physical activity guidelines only in terms
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of ambulatory activity. For those who swim and cycle (e.
g., stationary or recumbent cycling), it may be possible
to consider adding ‘bonus steps’ to daily totals to
account for these extra non-ambulatory activities [71].
For example, Miller et al. [71] suggest adding 200 steps
for every minute of non-ambulatory activities like
cycling or swimming. De Greef et al. [72] have
instructed participants in pedometer-based interventions
to add 150 steps to their daily total for every minute
engaged in cycling and/or swimming.
On face value, a step is the fundamental component of
walking; it represents the initiation of body weight
transfer and a basic expression of human mobility.
Cadence, or steps/minute, is a reasonable indicator of
speed [73] and is also related to the intensity of ambula-
tion [41-45], and can theoretically capture the “purpose-
fulness” of ambulatory activity. As steps are
accumulated more rapidly and continuously, an indivi-
dual can be said to be walking purposefully, that is, to
get somewhere and/or for exercise. Of course, running
is represented at the highest cadences, but this is not
likely applicable to many older adults or individuals liv-
ing with disability or chronic illness. As mentioned
above, 100 steps/minutes is a cadence that is growing in
acceptance as a heuristic value indicative of walking at
an absolutely-defined intensity of 3 MET intensity, at
least in younger adults [41-45]. This cadence may be
unrealistic for many older adults (especially for those
who are more frail) or for those living with disability or
chronic illness. It may be useful to embrace a “some-
thing is better than nothing” approach [5], or even a
“better than usual” approach, in terms of setting relative
goals for such special populations.
The correlation between age and preferred walking
speed in a population study of older adults 60-86 years
of age was -.34 (women) and -.41 (men) [74]. Those liv-
ing with disability or chronic illness may walk at even
slower speeds [75]. Overall, aging, disabled, and ill older
adults may gradually lose their ability to walk at higher
cadences and what remains is the “pottering” (i.e., ran-
dom, unplanned movements) associated with activities
of daily living that all ages appear to engage in to some
extent [76]. Slow walking speed in older adults is
strongly associated with increased risk of cardiovascular
mortality [77]. Since public health guidelines for older
adults continue to emphasize the importance of engage-
ment in aerobic activities that are of at least moderate
intensity, it follows that any step count translation also
reflects this emphasis. Although pedometers have been
widely criticized for not being sensitive to detecting
slow walking, their ability to “censor” low force accelera-
tions might actually be seen as a feature that permits a
concerted focus on only those steps that are more likely
to be beneficial to health [78].
Regardless, the interest in detecting even very low
force accelerations is evident from research studies
focused on physical activity behaviours of older adults
[13,79] and especially of individuals living with disability
and chronic illness [14] that have been adopting the
StepWatch Activity Monitor (SAM, CYMA Corporation,
Mountlake Terrace, WA). The SAM is an ankle worn-
accelerometer that detects a “stride” or “gait cycle.” To
be interpreted relative to more traditional waist-
mounted instruments (both accelerometers and ped-
ometers), its output needs to be doubled and expressed
as steps. However, this instrument is designed to be
exceptionally sensitive to slow gaits [80] (and is also
more likely to detect “fidgeting” activities [80]) and
therefore its output would appear higher than that of
more traditional pedometers [17]. For example, a sample
of older adults (mean age 83 years) who wore the SAM
for 6 consecutive days averaged approximately 10,000
steps/day [81], or ‘active’ if directly (and inappropriately)
interpreted against the graduated step index based on
pedometer output [15,16]. The SAM remains an impor-
tant research tool, however, it is less practical for public
health applications. No conversion factor exists at this
time to assist in translation of SAM-detected steps to
that of pedometers that have been more traditionally
used in research and practice.
Another instrument, the ActiGraph accelerometer, is
also known to be more sensitive to lower force accelera-
tions ([82-84]) and its output from earlier models
needed to be manipulated in order to interpret it against
existing pedometer-based scales [15,16]. More recently,
the manufacturers of this instrument have offered a ‘low
extension’ option that can be selected, or deselected,
depending on sensitivity requirements. Since pedometers
are more likely to be adopted by a range of users includ-
ing researchers, practitioners, and the general public,
and since public health guidelines specifically emphasize
MVPA (and not lighter intensity activities), the step-
based translations presented in this article are intention-
ally more reflective of what would be expected from the
use of good quality pedometers. Although the need to
detect less forceful steps, especially in some clinical
populations can be justified, it remains a concern that
comparisons between datasets collected with different
devices are hampered unless acceptable conversion fac-
tors to facilitate such interpretation can be determined.
Regardless of the choice of instrumentation, normative
step values for older adults and special populations span
a very wide range. Although the graduated step index
described above offers a definite improvement over eva-
luation using any single step value (e.g., 10,000 steps/
day), even smaller increments would provide additional
“rungs on the ladder” and represent a more continuous
and fully expanded steps/day scale. Specifically, 1,000
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step increments [41-45] are congruent with the concept
of 10-minute bouts taken at 100 steps/min or minimally
moderate intensity [3,5], and three 10-minutes bouts (i.
e., 3 × 1,000 steps = 3,000 steps) are congruent with a
daily 30-minute minimally moderate intensity physical
activity recommendation. Figure 1 presents the fully
expanded steps/day scale. The scale begins at zero and
continues to 18,000+ steps/day, representing the single
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Figure 1 Steps/day scale schematic linked to time spent in MVPA.
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highest average value reported for a sample at this time
in Amish men [85]. Although all age groups are repre-
sented, the one-way arrows identify step-based transla-
tions of population-specific public health guidelines
contained herein (and separately reviewed in companion
papers) but also suggest that more is better. For exam-
ple, the range for healthy older adults is 7,000-10,000
steps/day, at least 3,000 of which should be accumulated
at a brisk pace. For individuals living with disability or
chronic illness the range is 6,500-8,500 steps/day
(although this is based on limited evidence at this time).
The difference between thresholds for adults 20-65
years of age and healthy older adults 65+ years of age is
nominal (i.e., approximately 300 steps), but it is based
on the empirical evidence assembled, and suggests that
apparently healthy older adults are capable of achieving
minimum steps/day for improving health. However,
quite clearly there is a larger gap at the upper end,
which reflects decreasing capacity with age (and disease
and disability) to achieve upper-end targets. Again, it is
important to emphasize, that the oldest-old, especially
those compromised by frailty, are more likely to be
described as a special population where a clinical
approach to increasing physical activity will more appro-
priately supersede a public health approach. Regardless,
adoption of this fully expanded steps/day scale applied
across the lifespan would facilitate communication, eva-
luation, and research. As evidence accumulates, it may
be possible to locate population-specific likelihoods of
achieving valued health-related outcomes along the
scale.
An important limitation must be emphasized. It is
well known that the measurement mechanism of accel-
erometers is more sensitive to lower force accelerations
(e.g., slow walking) and therefore this type of instrumen-
tation will detect more steps than simple pedometers.
However, there are no data at this time to inform us
about the health value of steps taken at very low inten-
sity steps independent of higher intensity steps. Indeed,
perhaps one contributory factor to age-related decline is
the decrease in intensity of daily movement and the pro-
gressive loss of higher intensity movements. This is
speculative. Regardless, the difference in instrument sen-
sitivity makes it so that the output of accelerometers
should generally not be directly interpreted against the
scaling presented herein. A direct conversion factor
between instruments is not known at this time, but
would certainly be useful. The continued use of BMI as
a useful, albeit imperfect, indicator of body fatness is an
appropriate analogy to the use of a pedometer as an
indicator of healthful levels of physical activity. Regard-
less, any step-based translation of current physical activ-
ity guidelines should clearly convey the importance of
making an appropriate portion of daily steps congruent
with undertaking recommended amounts and bouts of
MVPA [86,87].
Conclusions
The very broad ranges of habitual activity evident from
normative data reflect the natural diversity of physical
capacity common to older adults and special popula-
tions. There is no evidence to inform an absolutely-
defined moderate intensity cadence specific to older
adults at this time. However, using the adult cadence of
100 steps/minute to denote the floor of absolutely-
defined moderate intensity walking, and multiplying this
by 30 minutes produces a reasonable heuristic value of
3,000 steps. To be a true translation of public health
guidelines these steps should be taken over and above
activities of everyday living, be of at least moderate
intensity accumulated in minimally 10 minute bouts (i.
e., at least 1,000 steps taken at a cadence of 100 steps/
min), and add up to at least 150 minutes spread out
over the week. Computed translations of this recom-
mendation approximate 8,000 daily steps and 7,100
steps/day if averaged over a week. Directly measured
estimates of free-living activity that include recom-
mended amounts of MVPA are not too different: 7,000
-10,000 steps/day. Recognizing that the most sedentary
older adults and individuals living with disability and
chronic illness may be more limited in their everyday
activities, but could still benefit from a physically active
lifestyle, a similarly computed translation approximates
5,500 daily steps or 4,600 steps/day if averaged over a
week of free-living behaviour. Direct evidence (measured
objectively by accelerometer) suggests a somewhat
higher range (6,500- 8,500 steps/day), however, it is
important to remember that this is based on a single
study of patients in a cardiac rehabilitation program.
Direct evidence is urgently needed for other special
populations. Individuals living with more physically lim-
iting conditions may demonstrate lower normative
values and thus may benefit from more individualized
daily step targets relative to their unique baseline values.
Health outcome-referenced values of steps/day appear
to differ in older adults depending upon which health-
related outcome is desired. All estimates herein express
translations of minimal recommendations, and more is
likely better.
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